Yes, there are certain exemptions to PREA requirements. For instance, drugs that are unlikely to be used in pediatric populations, such as those for certain adult-specific conditions, may be exempt. Additionally, the FDA may grant waivers or deferrals if conducting pediatric studies is not feasible or if the drug is intended to treat a condition that does not occur in children.